# ¶ 24.01    Heading for Sequence Requirements

**REQUIREMENTS FOR PATENT APPLICATIONS CONTAINING NUCLEOTIDE AND/OR AMINO ACID SEQUENCE DISCLOSURES**

**Items 1) and 2) provide general guidance related to requirements for sequence disclosures.**

- 1) **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  requires that patent applications which contain disclosures of nucleotide and/or amino acid sequences that fall within the definitions of **[37 CFR 1.821(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333661)**  must contain a "Sequence Listing," _as a separate part of the disclosure_ , whichpresents the nucleotide and/or amino acid sequences and associated information using the symbols and format in accordance with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  . This "Sequence Listing" part of the disclosure may be submitted:
    - a) In accordance with **[37 CFR 1.821(c)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201ad_14c)**  via the USPTO patent electronic filing system (see Section I.1 of the Legal Framework for Patent Electronic System( **[https://www.uspto.gov/PatentLegalFramework](https://www.uspto.gov/PatentLegalFramework)**  ), hereinafter "Legal Framework") as an ASCII text file, together with an incorporation-by-reference of the material in the ASCII text file in a separate paragraph of the specification as required by **[37 CFR1.823(b)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333837.html##ar_it_337f1_2128f_369)**  identifying:
        - i) the name of the ASCII text file;
        - ii) the date of creation; and
        - iii) the size of the ASCII text file in bytes;
    - b) In accordance with **[37 CFR1.821(c)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201ad_14c)**  on read-only optical disc(s) as permitted by **[37 CFR1.52(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##d0e318536)**  , labeled according to **[37 CFR1.52(e)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##d0e318582)**  , with an incorporation-by-reference of the material in the ASCII text file according to **[37 CFR1.52(e)(8)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##ar_it_337ef_1ec06_58)**  and **[37 CFR1.823(b)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333837.html##ar_it_337f1_2128f_369)**  in a separate paragraph of the specification identifying:
        - i) the name of the ASCII text file;
        - ii) the date of creation; and
        - iii) the size of the ASCII text file in bytes;
    - c) In accordance with **[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)**  via the USPTO patent electronic filing system as a PDF file(not recommended); or
    - d) In accordance with **[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)**  on physical sheets of paper (not recommended).
- 2) When a "Sequence Listing" has been submitted as a PDF file as in 1.c) above ( **[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)**  ) or on physical sheets of paper as in 1. d) above ( **[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)**  , **[37 CFR1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  ), requires a computer readable form (CRF) of the "Sequence Listing" in accordance with the requirements of **[37 CFR 1.824](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334418.html)**  .
    - a) If the "Sequence Listing" required by **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  is filed via the USPTO patent electronic filing system as a PDF,then **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**  requires submission of a statement that the"Sequence Listing" content of the PDF copy and the CRF copy (the ASCII text file copy) are identical.
    - b) If the "Sequence Listing" required by **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  is filed on paper or read-only optical disc,then **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**  requires submission of a statement that the"Sequence Listing" content of the paper or read-only optical disc copy and the CRF are identical.

**Specific deficiencies and the required response to this Office Action are as follows:**

### Examiner Note:

1. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

2. This form paragraph must be followed by any of form paragraphs **[24.02](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.02.html)** **[24.16](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.16.html)** .

# ¶ 24.02    No Sequence Listing part of the disclosure and No CRF

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  because it does not contain a "Sequence Listing" as a separate part of the disclosure or a CRF of the "Sequence Listing".

**Required response** - Applicant must provide:

- • A "Sequence Listing" part of the disclosure; **together with**
- • **An amendment specifically directing its entry into the application in accordance with**[37 CFR 1.825(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  ;**
- • A statement that the "Sequence Listing" includes no new matter as required by **[37 CFR 1.825(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c70_2c8)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(a)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c57_2cc)**.
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) a) or b) above,
- Applicant must also provide:
    - o A substitute specification in compliance with **[37 CFR 1.52,](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**  **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
        - - A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        - - A copy of the amended specification without markings (clean version); and
        - - A statement that the substitute specification contains no new matter.
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) b), c), or d) above, Applicant must also provide:
    - o A CRF in accordance with **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  or **[1.821(e)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2036c_30e)**  as required by **[1.825(a)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c7e_f8)**; and
    - o A statement according to item 2) a) or b) above.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application that has no "Sequence Listing" part of the disclosure as required by **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  and no CRF as required by **[37 CFR 1.821(e)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333722)**.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.03    No Sequence Listing part of the disclosure and Defective CRF

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  because it does not contain a "Sequence Listing" as a separate part of the disclosure and the CRF of the "Sequence Listing" is defective.

**Required response** - Applicant must provide:

- • A "Sequence Listing" part of the disclosure, as described above in item 1); **together with**
- • **An amendment specifically directing its entry into the application in accordance with **[37 CFR 1.825(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25beb_3ac)**;**
- • A statement that the "Sequence Listing" includes no new matter as required by **[37 CFR 1.825(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c70_2c8)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(a)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**.
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) a) or b) above, Applicant must also provide:
    - o A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
        - - A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        - - A copy of the amended specification without markings (clean version); and
        - - A statement that the substitute specification contains no new matter.
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) c) or d) above, Applicant must also provide:
    - o A CRF in accordance with **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  or **[1.821(e)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2036c_30e)**  as required by **[37 CFR 1.825(a)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c7e_f8)**; and
    - o A statement according to item 2) a) or b) above.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application that has no "Sequence Listing" part of the disclosure as required by **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  and the CRF as required by **[37 CFR 1.821(e)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333722)**  is defective.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.05    The "Sequence Listing" part of the disclosure and the CRF are not the same

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  because the "Sequence Listing" part of the disclosure submitted as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or on physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** )is not the same as the CRF of the "Sequence Listing" as required by **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**.

**Required response** - Applicant must provide:

- • A replacement "Sequence Listing" as described above in items 1) c) or d) in accordance with **[37 CFR 1.825(b)(1)(ii) or (iii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25daa_3c)**; **as well as**
- • **An amendment specifically directing its entry into the application as required by **[37 CFR 1.825(b)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e4c_2b3)**;**
- • A statement that identified the locations of any deletions, replacements or additions to the "Sequence Listing" as required by **[37 CFR 1.825(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e63_35f)**;
- • A statement that the "Sequence Listing" added by amendment includes no new matter as required by **[37 CFR 1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**;
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**; and
- • A statement that the content of the previously-filed CRF is identical to the "Sequence Listing" part of the disclosure added by amendment as required by **[37 CFR 1.825(b)(7)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ece_376)**, where provided under item 1) c) or d) (note that where a "Sequence Listing" part of the disclosure is provided under item 1) a) or b), the text file will also serve as the CRF, and the statement of identity is not required);

OR

- • A CRF as required by **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  or **[1.821(e)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2036c_30e)**; and
- • A statement that the content of the CRF is identical to the "Sequence Listing" part of the disclosure previously submitted as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or on physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** ), as required by **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**.

### Examiner Note:

1. This form paragraph must be preceded by **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application in which the "Sequence Listing" part of the disclosure as required by **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  is not the same as the CRF as required by **[37 CFR 1.821(e)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333722)**.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.06    Missing statement that the "Sequence Listing" (paper or PDF) and the CRF are the same

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  because the application does not contain a statement that the CRF is identical to the "Sequence Listing" part of the disclosure, as described above in item 1), as required by **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**.

**Required response** - Applicant must provide such statement.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application that is missing the statement that the CRF is identical to the "Sequence Listing" part of the disclosure.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.07    No Computer Readable Form (CRF) submitted

**Specific deficiency** - This application contains a "Sequence Listing as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or as physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)**, but fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**  because a copy of the "Sequence Listing" in computer readable form (CRF) has not been submitted as required by **[37 CFR 1.821(e)(1)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20340_c7)**  or **[1.821(e)(2)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20728_1b9)**  as indicated in item 2) above.

**Required response** - Applicant must provide:

- • A new CRF of the "Sequence Listing" in accordance with 37 **[37 CFR 1.821(e)(1)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20340_c7)**  or **[1.821(e)(2)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20728_1b9)**  and
- • A statement that the content of the CRF is identical of the "Sequence Listing" part of the disclosure, submitted as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or on physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** ), as required by **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application that is missing the CRF.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.08    Computer Readable Form (CRF) contains error(s) according to STIC report

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**. This application contains a "Sequence Listing" as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)** ) or as physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** ). A copy of the "Sequence Listing" in computer readable form (CRF) has been submitted; however, the content of the CRF does not comply with one or more of the requirements of **[37 CFR 1.822](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333753.html)**  through **[1.824](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334418.html)**, as indicated in the "Error Report" that indicates the "Sequence Listing" could not be accepted. Refer to attachment or document "Computer Readable Form (CRF) for Sequence Listing – Defective" dated **[1]**.

**Required response** – Applicant must provide:

- • A replacement "Sequence Listing" part of the disclosure, as described above in item 1); **together with**
- • **An amendment specifically directing its entry into the application in accordance with **[37 CFR 1.825(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e03_1ec)**** ;
- • A statement that the "Sequence Listing" includes no new matter as required by **[37 CFR 1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**.
- • If the replacement "Sequence Listing" part of the disclosure is submitted according to item 1) a) or b) above, Applicant must also provide:
    - o A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
        - - A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        - - A copy of the amended specification without markings (clean version); and
        - - A statement that the substitute specification contains no new matter and
        - - An amendment to the specification to remove the "Sequence Listing previously submitted as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or as physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** )
- • If the replacement "Sequence Listing" part of the disclosure is submitted according to item 1) c) or d) above, Applicant must also provide:
    - o A CRF in accordance with **[1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  or **[1.821(e)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2036c_30e)**  as required by **[37 CFR 1.825(b)(6)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_33844_139b5_78)**; and
    - o Statement according to item 2) a) or b) above.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application where the CRF is defective.

4. In bracket 1, insert the date of the appropriate document.

5. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.09    Computer Readable Form (CRF) damaged or unreadable

**Specific deficiency** - The ASCII .txt file purported to contain the computer readable form (CRF) copy of the "Sequence Listing" filed with this application in accordance with **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  has been found to be damaged, unreadable, or otherwise contains an error as indicated on document "Computer Readable Form (CRF) for Sequence Listing - Defective" dated.

**Required response** – Applicant must provide:

- • a replacement "Sequence Listing" in the form of an ASCII plain text file under **[37 CFR 1.821(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  as provided for in **[37 CFR 1.825(b)(1)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25daa_3c)**, together with
- • An amendment specifically directing its entry into the application in accordance with **[37 CFR 1.825(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e63_35f)**;
- • A statement that the "Sequence Listing" includes no new matter as required by **[37 CFR 1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**.
- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
    - • A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - • A copy of the amended specification without markings (clean version); and
    - • A statement that the substitute specification contains no new matter;
- OR
- • A "Sequence Listing" part of the disclosure, as described above in item 1 c) or 1 d) as provided for in **[37 CFR 1.825(b)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25dea_215)**  or **[1.825(b)(1)(iii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_33844_1394e_3e0)**; **together with**
- • An amendment specifically directing its entry into the application in accordance with **[37 CFR 1.825(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e03_1ec)**;
- • A statement that the "Sequence Listing" includes no new matter as required by **[37 CFR 1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**.
- • When the "Sequence Listing" part of the disclosure is submitted according to item 1 c), or 1 d) above, Applicant must also provide:
    - • A CRF in accordance with **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  as required by **[37 CFR 1.825(b)(6)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ebd_1de)**; and
    - • a statement according to item 2) a) or b) above.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application where the CRF is damaged or unreadable, e.g., SCORE - CRF Problem Report.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.10    Sequence IDs not present in the specification

**Specific deficiency** - Nucleotide and/or amino acid sequences appearing in the specification are not identified by sequence identifiers in accordance with **[37 CFR 1.821(d)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333718)**.

**Required response** – Applicant must provide:

- • a substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required sequence identifiers, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application where reference has not been made to the sequence by use of the sequence identifier, preceded by "SEQ ID NO:" in the text of the description or claims, even if the sequence is also embedded in the text of the description or claims of the patent application.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.11    Sequence IDs not present in the drawings

**Specific deficiency** - Nucleotide and/or amino acid sequences appearing in the drawings are not identified by sequence identifiers in accordance with **[37 CFR 1.821(d)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333718)**. Sequence identifiers for nucleotide and/or amino acid sequences must appear either in the drawings or in the Brief Description of the Drawings.

**Required response** – Applicant must provide:

- • Replacement and annotated drawings in accordance with **[37 CFR 1.121(d)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323179)**  inserting the required sequence identifiers;

AND/OR

- • a substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required sequence identifiers into the Brief Description of the Drawings, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application where reference has not been made to the sequence by use of the sequence identifier, preceded by "SEQ ID NO:" in either the text of the drawings or the Brief Description or the Drawings.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.12    Sequences present in the specification or drawings that are not in the CRF or listing

**Specific deficiency** - This application contains sequence disclosures in accordance with the definitions for nucleotide and/or amino acid sequences set forth in **[37 CFR 1.821(a)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333674)**  and **[(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333683)**. However, this application fails to comply with the requirements of **[37 CFR 1.821](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html)**  - **[1.825](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html)**.

The sequence disclosures are located **[1]**.

**Required response** – Applicant must provide:

- • A "Sequence Listing" part of the disclosure, as described above in item 1); **as well as**
- • **An amendment specifically directing entry of the "Sequence Listing" part of the disclosure into the application in accordance with 1.825(b)(2);**
- • A statement that the "Sequence Listing" includes no new matter in accordance with **[1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**; and
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**.
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) a) or b) above, Applicant must also provide:
    - o A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
        - - A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        - - A copy of the amended specification without markings (clean version); and
        - - A statement that the substitute specification contains no new matter;
- • If the "Sequence Listing" part of the disclosure is submitted according to item 1) b), c), or d) above, Applicant must also provide:
    - o A replacement CRF in accordance with **[1.825(b)(6)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ebd_1de)**; and
    - o Statement according to item 2) a) or b) above.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should be used for an application containing sequence disclosures that are not contained in the Sequence Listing or CRF.

4. In bracket 1, insert the specific location of the sequence disclosures that are not contained in the Sequence Listing or CRF.

5. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.13    Missing or Defective Incorporation by Reference Paragraph

**Specific deficiency** - The Incorporation by Reference paragraph required by **[37 CFR 1.821(c)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##d0e333702)**  is missing or incomplete. See item 1) a) or 1) b) above.

**Required response** – Applicant must provide:

- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should only be used for a sequence listing under 1) a) or 1) b) in form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**, where the incorporation-by-reference paragraph is missing.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.14    Amendment Missing Instruction to Enter the "Sequence Listing" into the Application

**Specific deficiency** – The "Sequence Listing" has not been entered into the application because the amendment does not direct entry of either the "Sequence Listing" (as required by **[37 CFR 1.825(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25beb_3ac)**  or **[1.825(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e03_1ec)** ) or contain the required Incorporation by Reference paragraph into the application.

**Required response** – Applicant must provide:

- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**  and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation-by-reference paragraph, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should only be used where the instruction to enter the "Sequence Listing" into the application is missing.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.15    Amendment Missing Statement of No New Matter

**Specific deficiency** – The "Sequence Listing" has not been entered into the application because the required statement of no new matter is missing. See **[37 CFR 1.825(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334418.html##d0e334445)**  or **[1.825(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25ead_350)**.

**Required response** – Applicant must provide:

- • A proper statement of no new matter.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should only be used for an amendment that is missing the statement of no new matter.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.16    Amendment Missing Statement of Support

**Specific deficiency** – The "Sequence Listing" has not been entered into the application because the required statement of support is missing. See **[37 CFR 1.825(a)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25c57_2cc)**  or **[1.825(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e334511.html##ar_it_337f1_25e75_1e1)**.

**Required response** – Applicant must provide:

- • A proper statement of support.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph **[24.01](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.01.html)**.

2. This form paragraph should only be used for sequence listing non-compliance where a compliant sequence listing is not required for examination of the application.

3. This form paragraph should only be used for an amendment that is missing the statement of support.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.17    Improper CRF transfer request

**Specific deficiency** - The present application contains a "Sequence Listing" submitted as either a PDF file pursuant to **[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)**  or as physical sheets of paper pursuant to **[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)**. No computer readable form (CRF) of the "Sequence Listing" pursuant to **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  has been received. In lieu of the CRF, Applicant has filed a request to transfer the CRF from a related or other application of the applicant to the present application to comply with the requirement in **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**. As of November 15, 2021, the practice of transferring a CRF from a previously-filed application of applicant into the present application in order to comply with **[37 CFR 1.821(e)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_202fe_ed)**  has been eliminated.

**Required response** - Applicant must provide:

- • A new CRF of the "Sequence Listing" in accordance with **[37 CFR 1.821(e)(1)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20340_c7)**  or **[1.821(e)(2)(i)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20728_1b9)**; and
- • A statement that the content of the CRF is identical to the "Sequence Listing" part of the disclosure submitted as a PDF file (**[37 CFR 1.821(c)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_201e3_302)** ) or on physical sheets of paper (**[37 CFR 1.821(c)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_2021f_f2)** ), as required by **[37 CFR 1.821(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20354_31)**  or **[1.821(e)(2)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e333653.html##ar_it_337f1_20740_5e)**.

### Examiner Note:

1. This form paragraph must be preceded by form paragraph 24.01.

2. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.17.26    Heading for ST.26 Sequence Requirements

**Summary of Requirements for Patent Applications Filed On Or After July 1, 2022, That Have Sequence Disclosures**

**[37 CFR 1.831(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211ca_219)**  requires that patent applications which contain disclosures of nucleotide and/or amino acid sequences that fall within the definitions of **[37 CFR 1.831(b)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211e4_8c)**  must contain a "Sequence Listing XML", _as a separate part of the disclosure,_ which presents the nucleotide and/or amino acid sequences and associated information using the symbols and format in accordance with the requirements of **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**. This "Sequence Listing XML" part of the disclosure may be submitted:

- 1. In accordance with **[37 CFR 1.831(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211ca_219)**  using the symbols and format requirements of **[37 CFR 1.832](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**  through **[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**  via the USPTO patent electronic filing system (see Section I.1 of the Legal Framework for Patent Electronic System (**[https:// www.uspto.gov/PatentLegalFramework](https://%20www.uspto.gov/PatentLegalFramework)** ), hereinafter "Legal Framework") in XML format, together with an incorporation by reference statement of the material in the XML file in a separate paragraph of the specification (an incorporation by reference paragraph) as required by **[37 CFR 1.835(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22952_1ae)**  or **[1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f1_306)**  identifying:
    - a. the name of the XML file
    - b. the date of creation; and
    - c. the size of the XML file in bytes; or
- 2. In accordance with **[37 CFR 1.831(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211ca_219)**  using the symbols and format requirements of **[37 CFR 1.832](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bde4_172.html)**  through **[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**  on read-only optical disc(s) as permitted by **[37 CFR 1.52(e)(1)(ii)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##d0e318536)**, labeled according to **[37 CFR 1.52(e)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##d0e318582)**, with an incorporation by reference statement of the material in the XML format according to **[37 CFR 1.52(e)(8)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html##ar_it_337ef_1ec06_58)**  and **[37 CFR 1.835(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22952_1ae)**  or **[1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f1_306)**  in a separate paragraph of the specification identifying:
    
    - a. the name of the XML file;
    - b. the date of creation; and
    - c. the size of the XML file in bytes.
    
    **SPECIFIC DEFICIENCIES AND THE REQUIRED RESPONSE TO THIS NOTICE ARE AS FOLLOWS:**
    

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be followed by one or more of form paragraphs **[24.18.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)** - **[24.29.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**.

# ¶ 24.18.26    No "Sequence Listing XML" part of the disclosure

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**  because it does not contain a "Sequence Listing XML" as a separate part of the disclosure. A "Sequence Listing XML" is required because <1>.

**Required response** - Applicant must provide:

- • A "Sequence Listing XML" part of the disclosure, as described above in item 1. or 2.; **together with**
    - o A statement that indicates **the basis for the amendment,** with specific references to particular parts of the application as originally filed, as required by **[37 CFR 1.835(a)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_2295b_75)**;
    - o A statement that the "Sequence Listing XML" includes no new matter as required by **[37 CFR 1.835(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22990_3e6)** 
- AND
- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation by reference paragraph as required by **[37 CFR 1.835(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22952_1ae)**, consisting of:
    -  A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    -  A copy of the amended specification without markings (clean version); and
    -  A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph 24.17.26.

3. This form paragraph should be used for an application that has no "Sequence Listing XML" in compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**. The examiner should explain why a "Sequence Listing XML" is required in <1>.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.19.26    Defective "Sequence Listing XML"

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**  because the "Sequence Listing XML," as a separate part of the disclosure, is defective, damaged or unreadable. Refer to document "Sequence Listing in Computer Readable Format is Defective " dated **[1]**.

**Required response** - Applicant must provide:

- • A replacement "Sequence Listing XML" part of the disclosure, as described above submitted in accordance with either item 1. or 2.; together with
    - o A statement that identifies the location of all additions, deletions or replacements of sequence information relative to the replaced "Sequence Listing XML" as required by **[37 CFR 1.835(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f8_158)**;
    - o A statement that indicates support for the replacement "Sequence Listing XML" in the application, as filed, as required by **[37 CFR 1.835(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229ff_bd)**; and
    - o A statement that the replacement "Sequence Listing XML" includes no new matter as required by **[37 CFR 1.835(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**.
- **AND**
- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**, inserting the required incorporation-by-reference paragraph as required by **[37 CFR 1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1 This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2 This form paragraph must be preceded by form paragraph 24.17.26.

3 This form paragraph should be used for an application where a defective "Sequence Listing XML" was filed and a notice was sent to the applicant including the errors identified according to STIC.

4 This form paragraph may be followed by one or more deficiency form paragraphs.

5 This form paragraph would only be used when an applicant provides a disc of a "Sequence Listing XML" in reply to an examiner requirement for a "Sequence Listing XML."

# ¶ 24.20.26    "Sequence Listing XML" contains errors according to STIC report

The "Sequence Listing XML" part of the disclosure filed with this application in accordance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**  has been found to contain an error or errors as indicated on the document "Computer Readable Form (CRF) for Sequence Listing - Defective" dated **[1]**. Applicant must provide:

- • A replacement "Sequence Listing XML" part of the disclosure, as described above submitted in accordance with either item 1. or 2., together with
    - o A statement that identifies the location of all additions, deletions, or replacements of sequence information in the replacement "Sequence Listing XML" as required by **[37 CFR 1.835(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f8_158)**;
    - o A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.835(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229ff_bd)**;
    - o A statement that the replacement "Sequence Listing XML" includes no new matter as required by **[37 CFR 1.835(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**; and
    - o A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation by reference paragraph as required by **[37 CFR 1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**, consisting of:
        -  A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        -  A copy of the amended specification without markings (clean version); and
        -  A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph 24.17.26.

3. This form paragraph should be used for an application where a defective "Sequence Listing XML" was filed and a notice was sent to the applicant including the errors according to STIC.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.21.26    Sequence IDs not present in specification

**Specific deficiency** - Sequences appearing in the specification are not identified by sequence identifiers (i.e., "SEQ ID NO:X" or the like) in accordance with **[37 CFR 1.831(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_212e3_322)**.

**Required response** – Applicant must provide: A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required sequence identifiers, consisting of:

- • A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
- • A copy of the amended specification without markings (clean version); and
- • A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph 24.17.26.

3. This form paragraph should be used for an application where a sequence is embedded in the text of the description or claims of the patent application and reference has not also been made to the sequence by use of the sequence identifier, preceded by "SEQ ID NO:" or the like in the text of the description or claims.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.22.26    Sequence IDs not present in drawings

**Specific deficiency** - Sequences appearing in the drawings are not identified by sequence identifiers in accordance with **[37 CFR 1.831(c)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_212e3_322)**. Sequence identifiers for sequences (i.e., "SEQ ID NO:X" or the like) must appear either in the drawings or in the Brief Description of the Drawings.

**Required response** – Applicant must provide:

Amended drawings in accordance with **[37 CFR 1.121(d)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323179)**  inserting the required sequence identifiers;

**AND/OR**

A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required sequence identifiers (i.e., "SEQ ID NO:X" or the like) into the Brief Description of the Drawings, consisting of:

- • A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
- • A copy of the amended specification without markings (clean version); and
- • A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where a sequence is embedded in the text of the drawings and reference has not also been made to the sequence by use of the sequence identifier, preceded by "SEQ ID NO:X" or the like, in either the text of the drawings or the Brief Description or the Drawings.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.23.26    Sequence in specification, drawings, or claims that is not in XML

This application contains sequence disclosures in accordance with the definitions for nucleotide and/or amino acid sequences set forth in **[37 CFR 1.831(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211ca_219)**  and **[1.831(b)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html##ar_it_35d57_211e4_8c)**. However, this application fails to comply with the requirements of **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**. The examiner has noted that **[1]**. Applicant must provide:

- • A replacement "Sequence Listing XML" part of the disclosure, as described above in item 1. or 2., as well as
- • A statement that identifies the location of all additions, deletions, or replacements of sequence information in the "Sequence Listing XML" as required by **[37 CFR 1.835(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**;
- • A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.835(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229ff_bd)**;
- • A statement that the "Sequence Listing XML" includes no new matter in accordance with **[37 CFR 1.835(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**; and
- • A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation by reference paragraph as required by **[37 CFR 1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**, consisting of:
    - o A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - o A copy of the amended specification without markings (clean version); and
    - o A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. Examiner needs to identify the sequences missing from the "Sequence Listing XML" that were found in the claims, drawing or specification in <1>.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.24.26    Missing, Defective, or Incomplete Incorporation by Reference Paragraph

**Specific deficiency** - The incorporation by reference paragraph required by **[37 CFR 1.834(c)(1)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html##ar_it_35d57_22889_c5)**, **[37 CFR 1.835(a)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22952_1ae)**, or **[1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f1_306)**  is missing, defective or incomplete.

**Required response** - Applicant must:

- • Provide a substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation by reference paragraph, consisting of:
    - • A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
    - • A copy of the amended specification without markings (clean version); and
    - • A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where incorporation by reference paragraph is missing, defective or incomplete. The examiner should clearly specify how any defective incorporation by reference paragraphs is non-compliant, if applicable.

4. The form paragraph maybe used when the incorporation by reference paragraphs provides erroneous information on the size of the sequence listing XML file, recites the size in kilobytes (KB) instead of bytes, and/or the file name for the sequence listing XML contains an error.

5. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.25.26    Amendment Missing Statement of No New Matter

**Specific deficiency** - The "Sequence Listing XML" has not been entered into the application because the required statement of no new matter, in accordance with **[37 CFR 1.835(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22990_3e6)**  or **[37 CFR 1.835(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**, is missing.

**Required response** - Applicant must submit a statement that the "Sequence Listing XML," identified by the date the "Sequence Listing XML" was filed, includes no new matter.

### Examiner Note:

1. This form paragraph should only be used where a compliant "Sequence Listing XML" is not required for examination of the application.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where the statement of no new matter is missing.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.26.26    Amendment Missing Statement of Support

**Specific deficiency** - The "Sequence Listing XML" has not been entered into the application because the required statement of support for the "Sequence Listing XML" in the application as filed, in accordance with **[37 CFR 1.835(a)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_2295b_75)**  or **[1.835(a)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22990_3e6)**, is missing.

**Required response** - Applicant must submit a proper statement that indicates the basis for the "Sequence Listing XML," with specific references to particular parts of the application as originally filed (specification, claims, drawings) for added, deleted and/or modified sequence data.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where the statement that indicates the basis for the "Sequence Listing XML" is missing.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.27.26    "Sequence Listing XML" contains foreign language text

**Specific deficiency** - This application fails to comply with the requirements of **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  because the language-dependent free text elements within the "Sequence Listing XML" are not in the English language, as required by **[37 CFR 1.833(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be20_17c.html##ar_it_35d57_226fe_1e8)**.

**Required response** - As required by **[37 CFR 1.835(d)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a4c_d8)**, applicant must provide a translated "Sequence Listing XML" part of the disclosure in compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.834](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be3b_1cf.html)**.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where the "Sequence Listing XML" contains foreign text in the language-dependent free text elements.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.28.26    "Sequence Listing XML" bibliographic information does not match application

**Specific deficiency** - The "Sequence Listing XML" submitted in the present application does not appear to be the correct sequence listing file. One or more of the following identifying information: invention title, applicant file reference, applicant name, inventor name, or earliest priority application do not match those in the official application.

**Required response** - Applicant must provide:

- • A replacement "Sequence Listing XML" part of the disclosure, as described above in item 1. or 2., as well as
    - o A statement that identifies the location of all additions, deletions, or replacements of sequence information in the replacement "Sequence Listing XML" as required by **[37 CFR 1.835(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f8_158)**;
    - o A statement that indicates support for the amendment in the application, as filed, as required by **[37 CFR 1.835(b)(4)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229ff_bd)**,
    - o A statement that the replacement "Sequence Listing XML" includes no new matter in accordance with **[37 CFR 1.835(b)(5)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_22a04_2c9)**, and
    - o A substitute specification in compliance with **[37 CFR 1.52](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e318327.html)**, **[1.121(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323020.html##d0e323094)**, and **[1.125](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//d0e323278.html)**  inserting the required incorporation by reference paragraph as required by **[37 CFR 1.835(b)(2)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//.html)**, consisting of:
        -  A copy of the previously-submitted specification, with deletions shown with strikethrough or brackets and insertions shown with underlining (marked-up version);
        -  A copy of the amended specification without markings (clean version); and
        -  A statement that the substitute specification contains no new matter.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where there is a discrepancy between the "Sequence Listing XML" bibliographic information and the application information in an application filed under **[35 U.S.C. 111(a)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//pltd0e302673aia.html##pltd0e302678aia)**, if the application is a national stage, then the examiner should contact IPLA.

4. This form paragraph may be followed by one or more deficiency form paragraphs.

# ¶ 24.29.26    Amendment Missing Statement of Location of Additions, Deletions or Replacements of Sequence Information

**Specific deficiency** - The "Sequence Listing XML" has not been entered into the application because the required statement that identifies the location of all additions, deletions or replacements of the sequence information relative to the replaced "Sequence Listing XML" is missing. See **[37 CFR 1.835(b)(3)](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html##ar_it_35d57_229f8_158)**.

**Required response** - Applicant must provide a proper statement identifying all changes in the replacement "Sequence Listing XML" relative to the replaced sequence data.

### Examiner Note:

1. This form paragraph should only be used where compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  is not required for examination of the application, or where a lack of compliance with **[37 CFR 1.831](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1bdc8_2b8.html)** -**[1.835](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//ar_d35d57_1be4d_1f4.html)**  arose during prosecution.

2. This form paragraph must be preceded by form paragraph **[24.17.26](https://mpep.uspto.gov/RDMS/MPEP/print?version=current&href=2400.html#//fp24.17.26.html)**.

3. This form paragraph should be used for an application where the replacement "Sequence Listing XML" is not accompanied by a statement that indicates the location of all additions, deletions or replacements in the sequence information.

4. This form paragraph may be followed by one or more deficiency form paragraphs.